cgs 26303 has been researched along with Neuralgia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LL; Cheng, KI; Chou, CW; Kwan, AL; Wang, HC | 1 |
1 other study(ies) available for cgs 26303 and Neuralgia
| Article | Year |
|---|---|
Intrathecal CGS-26303 Pretreatment Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain in the Spinal Cord.
Topics: Analgesics; Animals; Down-Regulation; Injections, Spinal; Ligation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuralgia; Organophosphonates; Rats, Sprague-Dawley; Spinal Nerves; Tetrazoles | 2016 |